Andrey Zarur
Co-Founder, President, & CEO @ Greenlight Biosciences
Medford, United States
Andrey Zarur is a Series A investor at Greenlight Biosciences in Medford focused on Medical and Education. Andrey Zarur is the Co-Founder, President & CEO at Greenlight Biosciences. Andrey leads Kodiak's investment efforts in Life Technologies. He focuses on a broad array of opportunities in life sciences including molecular diagnostics, medical devices, biomaterials, and drug discovery platforms. He represents Kodiak on the boards of AllegroDiagnostics, Astadia, Fluxion Biosciences, Lumicell, and GreenLight Biosciences.Prior to joining Kodiak in 2006, Andrey was the Founder and CEO of BioProcessors (sold to Seahorse Biosciences). During his career as an entrepreneur, Andrey has been involved in the conception, founding, launching and operations of over a dozen startups in life sciences and sustainable technologies. In addition, he is an Overseer of the Museum of Science in Boston and a Senior Lecturer at the Massachusetts Institute of Technology. In 2005 he was elected as a Young Global Leader of the World Economic Forum.
- Total investments:
- 1
- Last investment:
- Lead investor:
- 100%
Last updated:
For AI agents: llms.txt
Industries Andrey Zarur invests in
Stages Andrey Zarur invests in
Countries Andrey Zarur invests in
Investment Focus
Industry
- Medical 1 (100%)
- Education 1 (100%)
- Biotechnology 1 (100%)
- Health Diagnostics 1 (100%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
Allegro Diagnostics
|
Allegro Diagnostics was founded in 2006 by Jerome Brody, M.D., and Avrum Spira, M.D., MSc, faculty at the Boston University School of Medicine and thought leaders in the field of pulmonology. The company is currently headquartered in Maynard, Massachusetts. | $4.5M / Series A / Mar 07, 2008 |
Co-Investors
About Greenlight Biosciences
GreenLight Biosciences is an integrated life sciences company with a cutting-edge platform to deliver higher-quality RNA at a lower cost and more quickly than was ever before possible. GreenLight develops RNA products and collaborates with industry leaders to advance vaccine development, pandemic preparation, crop management, plant protection andsupport the health of bees and other pollinators.
Greenlight Biosciences Contacts
| Name | Phone | Socials | |
|---|---|---|---|
Amin Khan
Chief Scientific Officer, Human Health R&D
|
|||
|
Andrey Zarur
Co-Founder, President, & CEO
|
|||
Carole Cobb
Chief Operating Officer
|
|||
Charu Manocha
Chief People Officer
|
|||
Drew Cunningham
Vice President of Platform Research & Development
|
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar stage
Recommended lists
FAQ
What does Andrey Zarur invest in?
Andrey Zarur invests primarily in Medical, Education and Biotechnology startups, most often at Series A stage. Most of the 1 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
When did Andrey Zarur last invest?
The most recent investment recorded for Andrey Zarur closed in Mar 2008. Shizune tracks 1 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
